Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report

Annapaola Mariniello, Eleonora Ghisoni, Luisella Righi, Annamaria Catino, Rita Chiari, Alessandro Del Conte, Fausto Barbieri, Fabiana Cecere, Alain Gelibter, Matteo Giajlevra, Hector Soto Parra, Clizia Zichi, Massimo DI Maio, Giorgio Valabrega, Silvia Novello

Research output: Contribution to journalArticlepeer-review


BACKGROUND/AIM: Double diagnosis of lung cancer (LC) and ovarian cancer (OC) is rare. Here, we describe patients with synchronous/metachronous LC and OC to identify common clinical and pathological patterns.

PATIENTS AND METHODS: Clinical, pathological and molecular data of patients diagnosed and treated at 30 European Institutions from 2008 to 2018 were retrieved and analysed. Whenever tissue was available, centralized pathology revision was performed.

RESULTS: A total of 19 cases were found; one was excluded at pathology revision. Most LCs were adenocarcinomas (15/18) and most OCs were high-grade serous (15/18) carcinomas. Of the 9 patients analysed, 7 carried oncogene-addicted LC (4 EGFR, 1 B-RAF and 2 ALK) and five out of 7 carried BRCA mutations. One patient with a germline-BRCA1 mutation received olaparib, resulting in a durable response of both malignancies. Median overall survival was 33 months.

CONCLUSION: In our series, most synchronous/metachronous LCs and OCs showed genetic alterations. Further analyses with wide NGS panel could shed light on the biological mechanisms driving their occurrence.

Original languageEnglish
Pages (from-to)2021-2026
Number of pages6
JournalIn vivo (Athens, Greece)
Issue number6
Publication statusPublished - Oct 31 2019


Dive into the research topics of 'Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report'. Together they form a unique fingerprint.

Cite this